E. Kubista

9.2k total citations · 1 hit paper
247 papers, 6.8k citations indexed

About

E. Kubista is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, E. Kubista has authored 247 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Oncology, 64 papers in Genetics and 56 papers in Cancer Research. Recurrent topics in E. Kubista's work include Estrogen and related hormone effects (49 papers), Breast Cancer Treatment Studies (47 papers) and HER2/EGFR in Cancer Research (39 papers). E. Kubista is often cited by papers focused on Estrogen and related hormone effects (49 papers), Breast Cancer Treatment Studies (47 papers) and HER2/EGFR in Cancer Research (39 papers). E. Kubista collaborates with scholars based in Austria, Germany and United States. E. Kubista's co-authors include K. Czerwenka, R. Jakesz, Christian F. Singer, Gernot Hudelist, Michael Gnant, H. Hausmaninger, Hellmut Samonigg, W. Kwasny, M. Manavi and Michael Seifert and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

E. Kubista

233 papers receiving 6.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer

2009 504 citations E. Kubista et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
E. Kubista	3.7k	2.4k	2.0k	1.6k	1.1k	247	6.8k
Christian F. Singer	3.0k 0.8×	2.1k 0.9×	2.0k 1.0×	1.5k 0.9×	983 0.9×	267	6.4k
P Sismondi	2.7k 0.7×	1.8k 0.8×	1.7k 0.8×	1.9k 1.2×	834 0.8×	188	6.9k
M. Kaufmann	3.6k 1.0×	2.5k 1.0×	1.6k 0.8×	1.2k 0.8×	828 0.8×	242	6.5k
Hellmut Samonigg	4.0k 1.1×	2.9k 1.2×	1.9k 1.0×	1.2k 0.7×	1.2k 1.1×	118	6.6k
Marcella Mottolese	3.1k 0.8×	1.5k 0.7×	3.5k 1.8×	526 0.3×	916 0.9×	224	7.2k
Hans-Jörg Senn	4.1k 1.1×	4.3k 1.8×	1.5k 0.8×	1.2k 0.8×	914 0.9×	83	7.2k
Elizabeth Claire Dees	4.5k 1.2×	2.9k 1.2×	3.0k 1.5×	684 0.4×	1.4k 1.3×	127	7.9k
Virginia F. Borges	4.8k 1.3×	1.8k 0.8×	1.4k 0.7×	795 0.5×	1.4k 1.3×	227	7.2k
Dean B. Evans	2.7k 0.7×	2.0k 0.9×	2.1k 1.1×	2.1k 1.3×	994 0.9×	107	5.6k
Robert S. Warren	3.9k 1.1×	1.5k 0.6×	3.5k 1.8×	847 0.5×	1.1k 1.1×	123	8.7k

Countries citing papers authored by E. Kubista

Since Specialization

Citations

This map shows the geographic impact of E. Kubista's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Kubista with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Kubista more than expected).

Fields of papers citing papers by E. Kubista

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Kubista. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Kubista. The network helps show where E. Kubista may publish in the future.

Co-authorship network of co-authors of E. Kubista

This figure shows the co-authorship network connecting the top 25 collaborators of E. Kubista. A scholar is included among the top collaborators of E. Kubista based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Kubista. E. Kubista is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huober, Jens, Peter A. Fasching, M. Barsoum, et al.. (2011). Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial. The Breast. 21(1). 27–33. 171 indexed citations

Gnant, Michael, Walter Schippinger, G. Luschin-Ebengreuth, et al.. (2009). アジュバント内分泌療法へのゾレドロン酸(ZOL)追加はホルモン応答性早期乳房腫瘍(HREBC)の閉経前女性の無病生存(DF)及び非再発生存(RFS)を改善する:オーストリア乳房腫瘍及び結腸直腸腫瘍研究グループ12(ABCSG-12)試験の多変量解析. Annals of Oncology. 20. 30. 1 indexed citations

Singer, Christian F., Daphne Gschwantler‐Kaulich, A. Fink-Retter, et al.. (2008). HER2 overexpression and activation, and tamoxifen efficacy in receptor-positive early breast cancer. Journal of Cancer Research and Clinical Oncology. 135(6). 807–813. 8 indexed citations

Fink-Retter, A., Daphne Gschwantler‐Kaulich, Gernot Hudelist, et al.. (2007). Differential spatial expression and activation pattern of EGFR and HER2 in human breast cancer. Oncology Reports. 18(2). 299–304. 13 indexed citations

Langer, Swen, C Singer, Gernot Hudelist, et al.. (2006). Jun and Fos family protein expression in human breast cancer: correlation of protein expression and clinicopathological parameters.. PubMed. 27(4). 345–52. 50 indexed citations

Hudelist, Gernot, Wolfgang J. Köstler, Daphne Gschwantler‐Kaulich, et al.. (2005). Serum EGFR levels and efficacy of trastuzumab-based therapy in patients with metastatic breast cancer. European Journal of Cancer. 42(2). 186–192. 23 indexed citations

Amatschek, Stefan, Ulrich Koenig, Herbert Auer, et al.. (2004). Tissue-Wide Expression Profiling Using cDNA Subtraction and Microarrays to Identify Tumor-Specific Genes. Cancer Research. 64(3). 844–856. 203 indexed citations

Kubista, E.. (2003). Behandlung klimakterischer Symptome nach Brustkrebs mit Liviel(R) - Die LIBERATE-Studie. Journal für Kardiologie (Krause & Pachernegg GmbH). 10(3). 16–19. 1 indexed citations

Hudelist, Gernot, Wolfgang J. Köstler, Johannes Attems, et al.. (2003). Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatment. British Journal of Cancer. 89(6). 983–991. 45 indexed citations

10.

Schindl, Monika, Sebastian F. Schoppmann, Hellmut Samonigg, et al.. (2002). Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.. PubMed. 8(6). 1831–7. 332 indexed citations

11.

Birner, P., Georg Oberhuber, Josefine Stani, et al.. (2001). Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer.. PubMed. 7(6). 1669–75. 159 indexed citations

12.

Kubista, E.. (2001). [Breast cancer: figures and facts].. PubMed. 151(21-23). 548–51. 14 indexed citations

13.

Obwegeser, R., Andreas Obruca, Leo Auerbach, E. Kubista, & H. Sinzinger. (1999). Axillary Metastases of an Occult Primary Carcinoma of the Breast—Discovered Only by99mTc-Tetrofosmin Scintigraphy. Gynecologic Oncology. 72(3). 418–420. 4 indexed citations

14.

Manavi, M., Andreas P. Berger, E Kučera, et al.. (1998). Amplification and Expression of the c-erbB-2 Oncogene in Müllerian-Derived Genital-Tract Tumors. Gynecologic Oncology. 71(2). 165–171. 5 indexed citations

15.

Krainer, Michael, Thomas Brodowicz, Robert Zeillinger, et al.. (1997). Tissue Expression and Serum Levels of HER-2/neu in Patients with Breast Cancer. Oncology. 54(6). 475–481. 72 indexed citations

16.

Czerwenka, K., et al.. (1996). Human papilloma virus DNA: A factor in the pathogenesis of mammary Paget's disease?. Breast Cancer Research and Treatment. 41(1). 51–57. 32 indexed citations

17.

Schön, H.J., et al.. (1993). Beta-endorphin, steroids, and prolactin. Immunoassay in breast cysts and blood.. PubMed. 117(3). 248–53. 3 indexed citations

18.

Schneeberger, Christian, G. Sliutz, E. Kubista, et al.. (1990). Determination of HER-2/neu amplification and expression in tumor tissue and cultured cells using a simple, phenol free method for nucleic acid isolation.. PubMed. 5(9). 1403–8. 40 indexed citations

19.

Czerwenka, K., H.J. Schön, Robert Zeillinger, E. Kubista, & J. Spona. (1989). Zellrezeptoren und Proliferationsmarker beim Mammakarzinom. Gyn�kologisch-geburtshilfliche Rundschau. 29(2). 400–401.

20.

Kubista, E., et al.. (1977). [Influence of social status on pregnancy, delivery and puerperium].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 127(11). 341–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact